Literature DB >> 6990956

A quantitative model for subcutaneous abscess formation in mice.

K A Joiner, A B Onderdonk, J A Gelfand, J G Bartlett, S L Gorbach.   

Abstract

The purpose of this experiment was to develop an experimental model of s.c. encapsulated abscesses in which abscess formation could be assessed by quantitative measurements. Inocula were composed of bacterial broth cultures, autoclaved mouse caecal contents or both in combination. These inocula were injected s.c. on the flank in 2 strains of mice. Large encapsulated abscesses formed in all recipients by Day 4 when the inoculum contained either B. fragilis or S. aureus combined with caecal contents. Bacterial concentrations per ml of pus at Day 6 were 10(10.1+/-0.02) for B. fragilis and 10(8.4+/-0.1) for S. aureus. Spontaneous external drainage began by 10--15 days, and complete healing of the lesion occurred by 4--6 weeks. The typical histological pattern consisted of a collagen capsule surrounding a rim of neutrophils, enclosing a central area of necrotic cells and fibre from the inoculum. The cross-sectional areas of the capsule, the neutrophil band and the entire abscess were measured in a reproducible manner by planimetry, and abscess volumes were calculated. Values for these measurements varied with different inocula and different times after inoculation, but were highly consistent for a specified time and inoculum.

Entities:  

Mesh:

Year:  1980        PMID: 6990956      PMCID: PMC2041559     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  18 in total

1.  Experimental staphylococcal infections in the skin of man.

Authors:  S D ELEK
Journal:  Ann N Y Acad Sci       Date:  1956-08-31       Impact factor: 5.691

2.  Comparison of subcutaneous and intraperitoneal staphylococcal infections in normal and complement-deficient mice.

Authors:  C S Easmon; A A Glynn
Journal:  Infect Immun       Date:  1976-02       Impact factor: 3.441

3.  The virulence enhancing action of mucins: a survey of human mucins and mucosal extracts for virulence enhancing activity.

Authors:  H SMITH
Journal:  J Infect Dis       Date:  1951 May-Jun       Impact factor: 5.226

4.  Use of semisolid agar from initiation of pure Bacteroides fragilis infection in mice.

Authors:  C B Walker; T D Wilkins
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

5.  Mechanisms of the adjuvant effect of hemoglobin in experimental peritonitis. I. In vivo inhibition of peritoneal leukocytosis.

Authors:  T Hau; R Hoffman; R L Simmons
Journal:  Surgery       Date:  1978-02       Impact factor: 3.982

6.  The effect of antilymphocyte serum on subcutaneous staphylococcal infections in normal, immune and complement-deficient mice.

Authors:  F A Medhurst; M J Hill; A A Glynn
Journal:  J Med Microbiol       Date:  1969-05       Impact factor: 2.472

7.  The production of subcutaneous staphylococcal skin lesions in mice.

Authors:  W C Noble
Journal:  Br J Exp Pathol       Date:  1965-06

8.  Contribution of T cell-mediated immunity to the resistance to staphylococcal infection.

Authors:  S Tsuda; Y Sasai; K Minami; K Nomoto
Journal:  J Invest Dermatol       Date:  1978-06       Impact factor: 8.551

9.  Antimicrobial therapy of experimental intraabdominal sepsis.

Authors:  W M Weinstein; A B Onderdonk; J G Bartlett; T J Louie; S L Gorbach
Journal:  J Infect Dis       Date:  1975-09       Impact factor: 5.226

10.  Experimental intra-abdominal abscesses in rats: quantitative bacteriology of infected animals.

Authors:  A B Onderdonk; W M Weinstein; N M Sullivan; J G Bartlett; S L Gorbach
Journal:  Infect Immun       Date:  1974-12       Impact factor: 3.441

View more
  15 in total

1.  In vivo efficacy of trovafloxacin against Bacteroides fragilis in mixed infection with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium in an established-abscess murine model.

Authors:  L E Stearne; I C Gyssens; W H Goessens; J W Mouton; W J Oyen; J W van der Meer; H A Verbrugh
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

2.  T-lymphocyte involvement in abscess formation in nonimmune mice.

Authors:  M F Nulsen; J J Finlay-Jones; P J McDonald
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

3.  Kinetics of growth and toxigenicity of Clostridium botulinum in experimental wound botulism.

Authors:  M Dezfulian; J G Bartlett
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

4.  Effect of the presence of black pigmented Bacteroides of differing pathogenicity on the phagocytosis of Escherichia coli by rat polymorphonuclear leucocytes.

Authors:  V Pancholi; A Ayyagari; K C Agarwal
Journal:  Med Microbiol Immunol       Date:  1985       Impact factor: 3.402

5.  Influence of daptomycin on staphylococcal abscesses and experimental tobramycin nephrotoxicity.

Authors:  C A Wood; H C Finkbeiner; S J Kohlhepp; P W Kohnen; D N Gilbert
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

6.  The effect of corticosteroids on subcutaneous abscess formation in the mouse.

Authors:  K A Joiner; J A Gelfand; J G Bartlett; S L Gorbach
Journal:  Br J Exp Pathol       Date:  1981-06

7.  Comparative therapeutic activities of ciprofloxacin, amoxicillin, ceftriaxone and co-trimoxazole in a new model of experimental infection with Escherichia coli.

Authors:  H Hof; A Christen; J Hacker
Journal:  Infection       Date:  1986 Jul-Aug       Impact factor: 3.553

8.  Efficacy of ofloxacin (HOE 280) in a model of subcutaneous abscess: penetration and prevention of abscess formation.

Authors:  M C García Iglesias; E J Perea
Journal:  Infection       Date:  1986       Impact factor: 3.553

9.  Comparison of single and combination antimicrobial agents for prevention of experimental gas gangrene caused by Clostridium perfringens.

Authors:  D L Stevens; B M Laine; J E Mitten
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

10.  Treatment of intra-abdominal abscesses caused by Candida albicans with antifungal agents and recombinant murine granulocyte colony-stimulating factor.

Authors:  Alieke G Vonk; Mihai G Netea; Johan H van Krieken; Paul E Verweij; Jos W M van der Meer; Bart Jan Kullberg
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.